GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. Net Income 2019–2025
GeneDx Holdings Corp. annual/quarterly net income history and growth rate from 2019 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- GeneDx Holdings Corp. net income for the quarter ending March 31, 2026 was -63.3 M, a 869.77% increase year-over-year.
- GeneDx Holdings Corp. net income for the twelve months ending March 31, 2026 was -66.7 M, a 33.34% decrease year-over-year.
- GeneDx Holdings Corp. annual net income for 2025 was -21.0 M, a 59.80% decrease from 2024.
- GeneDx Holdings Corp. annual net income for 2024 was -52.3 M, a 70.25% decrease from 2023.
- GeneDx Holdings Corp. annual net income for 2023 was -175.8 M, a 67.98% decrease from 2022.
- GeneDx Holdings Corp. annual net income for 2022 was -549.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GeneDx Holdings Corp. Net Income — FAQ
GeneDx Holdings Corp. (WGS) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is GeneDx Holdings Corp.'s net income?
GeneDx Holdings Corp. (WGS) reported net income of -$21M for fiscal 2025.
Where can I see WGS's net income history?
The chart and table above show GeneDx Holdings Corp.'s net income by year and by quarter, including the growth rate.